1/71
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai | Chat |
|---|
No analytics yet
Send a link to your students to track their progress
The Autonomic nervous system (ANS) automatically controls involuntary body functions, including
Blood pressure
Heart rate
Breathing
Digestion and intestinal movement
Salivary and other glandular secretions
Pupil size
Bladder function
Most autonomic messages follow a two neuron pathway
The brain or spinal cord sends an electrical signal through a PREganglionic neuron
The PREgangleonic neuron releases acetylcholine (ACh)
ACh crosses the synapse and binds to a nicotine receptor in a ganglion
This starts a new electrical signal in the POSTgangleonic neuron
The POSTgangleonic neuron releases another neurotransmitter at the target organ
The neurotransmitter binds to a receptor, causing the organ to respond
A GANGLION is:
a cluster of nerve cells that act as a relay station
A RECEPTOR is:
a protein on a cell that receives the neurotransmitters message and tells the cell how to respond
PARAsympathetic system
Nickname - Rest & Digest
Primary purpose - Conserves energy & maintains routine function
Origin - Brain stem & sacral spinal cord
PREganglionic fibers - Long
POSTganglionic fibers - Short
PREganglionic neurotransmitter - Acetylcholine
POSTganglionic neurotransmitter - Acetylcholine
Target receptors - Muscarinic
SYMPathetic
Nickname - Fight or flight
Primary purpose - Prepares the body for stress or emergencies
Origin - Thoracic & Lumbar spinal chord, T1-L2
PREganglionic fibers - Short
POSTganglionic fibers - Long
PREganglionic neurotransmitter - Acetylcholine
POSTganglionic neurotransmiter - Usually, norepinephrine
Target receptors - Alpha & Beta adrenergic
The parasympathetic system supports routine body maintenance:
Constricts the pupils
Slows the heart rate
Constricts the bronchioles & increases respiratory secretions
Stimulates digestion and intentional movement
Produces more watery saliva
Contracts the bladder & promotes urination
The sympathetic system prepares the body to respond to stress
Dilates the pupils
Increases heart rate and force of contraction
Dilates bronchioles
Slows digestion
Produces a smaller amount of thick, viscous saliva
relaxes the bladder, contributing to urinary retention
Constricts many blood vessels, increasing blood vessels
Acetylcholine
All sympathetic PREganglionic neurons release acetylcholine (ACh). ACh binds to nicotine receptors in the sympthetic ganglia and starts the POSTganglionic nerve signal.
Norepinephrine
Most sympathetic POSTganleonic neurons release norepinephrine at the target organ. Norepinephrine binds primarily to ALPHA & BETA adrenergic receptors.
Epinephrine
The adrenal medulla functions like a large sympathetic ganglion. When stimulated, it releases epinephrine into the bloodstream. Epinephrine travels throughout the body and intensifies the flight or fight response.
The neurotransmitter carries the message, but
the receptor determines how the organ responds
The same neurotransmitter
Can produce different effects depending on which receptor receives it
Receptor: Nicotine
main location/action - autonomic ganglia
Result of stimulation - Starts the POSTganglionic nerve signal
Receptor: a1
Main location/action - Blood vessels
Result of stimulation - Vasoconstriction and increased blood pressure
Receptor: a2
Main location/action - Presynaptic nerve endings
Result of stimulation - Decreases norepinephrine release
Receptor: B1
Main location/action - Heart
Result of stimulation - Increases heart rate and force of contraction
Receptor: B2
Main location/action - Lungs
Result of stimulation - Relaxes bronchial smooth muscle and opens the airway
Receptor: B3
Main location/action - Bladder
Result of stimulation - Relaxes the bladder muscle & promotes urine storage
Drug: Epinephrine
Stimulates a1, b1, & b2 receptors. It raises blood pressure, stimulates the heart, and opens the airways
Drug: Norepinephrine
Acts mainly on a1 receptors, producing strong vasoconstriction and increasing blood pressure
Drug: Phenylephrine
Primarily stimulates a1 receptors
Drug: albuterol & levalbuterol
Stimulates B2 receptors and quickly open the airways
Drug: Salmeterol
Is a long acting B2 agonist used for maintenance, not for an acute asthma attack
Drug: Clonidine
Stimulates a2 receptors, decreasing norepinephrine release and lowering sympathetic activity
Drug: Doxazosin
Blocks a1 receptors, allowing blood vessels to relax
Atenolol & metoprolol
Primarily block B1 receptors and slow the heart
Drug: Propranolol & Timolol
Block both B1 & B2 receptors, blocking B2 may narrow the airways, so these drugs require caution in patients with asthma or COPD
Epinephrine in a local anesthetic stimulates a1 receptors & causes vasoconstriction, This:
Reduces bleeding
Slows absorption into the bloodstream
Keeps the anesthetic near the injection site
Prolongs the duration of anesthesia
Reduces the risk of systemic toxicity
Use epinephrine cautiously in pts with:
Uncontrolled hypertension
Unstable angina
Uncontrolled hyperthyroidism
Recent cocaine or meth use
Nonselective beta-blocker therapy
Combining epinephrine with nonselective beta block can:
Produce excessive a1 - mediated vasoconstriction and significant rise in blood pressure
Cholinergic agents are also called
Cholinergic agonists or parasympathomimetics
Cholinergic agents
Imitate acetylcholine or increase Cholinergic activity, they deliver additional acetylcholine messages, causing the organs to respond more strongly
Most Cholinergic agents used for xerostomia:
Stimulate muscarinic receptors and increase parasympathetic activity
Their effects include:
Increased salivary flow
Increased tear production
Slower heart rate
Pupil constriction
Increased digestion & intestinal movement
Increased urination
Bronchial constriction and increased respiratory secretions
Cholinergic Drugs: Pilocarpine (Salagen)
Stimulates muscarinic receptors
Increases salivary flow
Used to treat xerostomia associated with Sjogren syndrome or head & neck radiatiation
Cholinergic Drugs: Cevimeline (Evoxac)
Stimulates muscarinic receptors
Increases salivary flow
Used to treat xerostomia associated with Sjogren syndrome
Adverse reaction of Cholinergic activity produces excessive rest & digest responses
S- Salivation
L- Lacrimation
U- Urination
D- Deification
Other possible adverse effects
Excessive sweating
Nausea or abdominal cramping
Diarrhea
Urinary urgency
Flushing
Headache or dizziness
Visual changes
Bradycardia
Hypotension
Bronchospasm or difficulty breathing
Cholinergic Drugs may be contraindicated or require caution in patients with:
Uncontrolled asthma
Conditions in which pupil constriction would be unsafe
Significant cardiovascular disease
Peptic ulcer disease
Urinary obstruction
Gastrointestinal obstruction
Contradictions depend on individual drug
Cholinergic agents can be beneficial because increased salivary flow may:
Improve speaking and swallowing
Improve denture comfort
Reduce oral dryness and mucosal irritation
Help protect against caries
Reduce the risk of oral infections associated with xerostomia
Nicotine stimulates:
Nicotine cholinergic receptors, it is not an anticholinergic drug and is not the same type of cholinergic medication used to treat xerostomia
Initially, nicotine stimulates receptors may increase
Heart rate
Blood pressure
Alertness
Gastrointestinal
With continued or high exposure:
The receptors can become desensitized, severe nicotine toxicity can cause respiratory muscle weakness and respiratory failure
Anticholinergic drugs are also called:
Cholinergic antagonists or parasympatholytics
Cholinergic antagonists:
Block acetylcholine from binding to muscarinic receptors, the nerve may still release ACh, but the target organ can not receive the message, there for rest & digest activity decreases
Blocking parasympathetic activity produces the following effects:
Decreased salivary flow
Increased heart rate
Decreased digestion and intestinal movement
Urinary retention
Dilated pupils and blurred vision
Decreased respiratory secretions
Bronchodilation
Cholinergic antagonists drugs: Atropine
Primary action/use - Muscarinic antagonist used for symptomatic bradycardia and to reduce secretions
Important effects - Increased heart rate and causes dry mouth
Cholinergic antagonist drug: Scopolamine
Primary action/use - Muscarinic antagonist used for motion sickness
Important effects - Dry mouth, blurred vision and drowsiness
Cholinergic antagonist drugs: Dimenhydrinate (Dramamine)
Primary action/use - Antihistamine with anticholinergic effects used for motion sickness
Important effects - Dry mouth, blurred vision and sedation
Cholinergic antagonist drugs: Loperamide (Imodium)
Primary action/use - Opioid receptor agonist that reduces intestinal movement
Important effects - May cause constipation and dry mouth
Important*
Lorperamide is not classified as an anticholinergic drug, it is a peripheral opioid receptor agonist, although it can produce similar effects such as reduced intestinal movement, constipation, and dry mouth
Adverse reactions to Cholinergic antagonists
Can’t see, can’t spit, can’t pee, can’t poop (shit)
This refers to :
Xerostomia
Urinary retention
Constipation
Dilated pupils and blurred vision
Additional adverse effects;
Tachycardia
Decreased sweating and heat intolerence
Drowsiness
Confusion
Memory problems
Increased risk of falls, particularly older adults
Anticholinergic drugs may be contraindicated or require caution in patients with:
Narrow-angle glaucoma
Urinary retention or an enlarged prostate
Gastrointestinal obstruction or ileus
Tachycardia or certain cardiac arrhythmias
Myasthenia gravis
Cognitive impairment, particularly in older adults
Contradictions vary by drug and dose
Xerorostomia is the most important dental effect, reduced saliva increases the risk of:
dental caries
root caries
candidiasis
mucosal soreness
difficulty swallowing, chewing or speaking
halitosis
Denture discomfort
Management may include:
Frequent water intake
Sugar-free xylitol-containing gum or lozenges when appropriate
Saliva substitutes
Prescription strength fluoride
Careful plaque control
More frequent caries assessments and preventative visits
Anticholinergic drugs with a hygienist
Should monitor patients’ pulse and blood pressure when appropriate and assess for dizziness, confusion, blurred vision or excessive sedation
Adrenergic agents are also called:
Adrenergic agonists or sympathomimetics imitate norepinephrine or epinephrine and increase fight-or-flight activity
Pharmacologic effects:
Depending on the receptor stimulated, adrenergic agents may:
Increase heart rate and force
Constrict blood vessels
Raise blood pressure
Dilate the bronchioles
Dilate the pupils
Decrease digestion
Redirect blood toward skeletal muscle
Adrenergic drug: Epinephrine
Primary receptor - a1, b1, b2
Main use or effect - Anaphylaxis, cardiac arrest, dental local anesthetics
Adrenergic drug: Norepinephrine
Primary receptor - Primarily a1 with some b1
Main use or effects - Severe hypotension and septic shock
Adrenergic drug: Phenylephrine
Primary receptor - a1
Main use or effects - Raises blood pressure and relieves nasal congestion
Adrenergic drug: Dopamine
Primary receptors - b1, a1 at higher doses
Main use or effect - Supports the heart and raises blood pressure in shock
Adrenergic drug: Albuterol
Primary receptor - b2
Main use or effect - Rapid relief bronchospasm
Adrenergic drug: Levalbuterol
Primary receptors - b2
Main use or effect -Rapid relief of bronchospasm
Adrenergic drug: Salmeterol
Primary receptor - b2
Main use or effect - Long term asthma or COPD maintenance
Chapter 4 core summary:
Cholinergic agonist - increases ACh activity - more rest & digest , more saliva
Anticholinergic drug - blocks muscarinic receptors - less rest & digest - dry mouth and increased heart rate
Adrenergic agonist - activates fight-or-flight messages - heart rate or blood pressure decreases
The receptor determines the response - a1 squeezes blood vessels, b1 stimulates the heart and b2 opens the lungs
What do neuromuscular blocking agents do
block communication between nerves and skeletal muscles, causing temporary muscle paralysis and relaxation
The main reason to balance general anesthesia
Combines drugs that target different goals so that each can be given at a lower dose
Guedel stages of anesthesia
Stage I - II: Transition to unconsciousness
Stage I: Analgesia/Disorientation: Begins with anesthetic administration and ends with loss of consciousness; breathing is regular, and protective reflexes are intact
Stage II: Excitment/delerium: Runs from loss of consciousness to automatic regular breathing; irregular respiration, involuntary movement, vomiting, laryngospasm, heightened reflexes may occur (spasmodic movements)
Clinical goal: Pass through stage II rapidly rather than maintaining the patient there
Stage III: Surgical anesthetic depth (4 planes)
Plane I: Regular spontaneous breathing; eyelid, conjunctival, and swallowing reflexes disappear
Plane II: Corneal and laryngeal reflexes are lost; muscle relaxation and respiratory depression increase
Plane III: Intercostal and abdominal muscle paralysis progresses, producing shallow respiration
Plane IIII: Intercostal paralysis is complete; diaphragmatic breathing remains but is profo
Stage IV: Overdose - never a target: Medullary depression causes apnea, severe hypotension or circulatory failure, and fixed dilated pupils; immediate resuscitation is required
Preferred three drugs for general anesthesia
Propofol (Most Common) - Rapid, smooth induction and maintenance; common adverse effects are hypotension and apnea; it provides no analgesia (no pain relief)
Etomidate: Rapid induction with relatively little cardiovascular depression; it may cause myoclonus (spasms) and adrenal suppression; no analgesia
Ketamine (Little bit of everything): Dissociative anesthesia with analgesia; spontaneous breathing and blood pressure are often preserved, but respiratory events can occur; secretions and emergence reactions are possible
Why the other drugs discussed are not the first choice
they carry higher risks of side effects, potential for dependence, or complex safety profiles compared to first-line treatments